About Jianshun Biosciences

Milestones

Shun Luo | FOUNDER, CHAIRMAN, JIANSHUN BIOSCIENCESManagement

Pin Milling

2 Parallel Dry Powder Manufacturing Lines

600 kgInstalled Blending

Capacity

Cell Culture Media Produc on

LanzhouJSBio

PD Lab & Cell Culture Media Facility 1

P2/P3R&D Lab

Designed by CRB Engineers, USA

> 1200 m2

Raw Material Warehouse

cGMPISO 9001

ISO 14001ISO 13485

Compliance

San Francisco, CA, USAPD Lab & USA HQ

ShanghaiJSBioPD Lab & East China S&M Centre

SingaporeBTI Collabora on Lab

HaimenJSBioCell Culture Media Facility 2, Planning

• Shanghai R&D center founded

2011 2012 2013 2014 2015 2016 20182017 2019

• JSB founded• P2/P3 PR&D lab• cGMP manufacturing facility

• Start DPM produc on• 1st Gen CD CHO media launch

• ISO 9001, ISO 14001 cer fica on• CD media for CHO/MDCK/ST/VERO… launch

• Signed coopera on agreement of EB66 with Valneva• NMPA Class 1 medical device

• Na onal Innova on Compe on Honors

• NMPA on-site audit• Vaccine market breakthrough

• As the preferred supplier of many industrial customers

• ISO 9001, ISO 14001, ISO 13485 cer fica on• Cooperate with BTI, Singapore

• CCM 2 facility: capacity scale-up• Overseas market breakthrough• Next genera on CD media project

Dr. Shun Luo is Founder and Chairman of Jianshun Biosciences Co., Ltd. Dr. Luo has more than 25 years of experience in biopharmaceu cal and biotechnology industries. He started his industry career as Principal Inves gator at Ares Serono Group. Later Dr. Luo worked for Beckman Coulter, JRH/SAFC Biosicences, Genentech, and Amgen with increasing responsibili es. His career spans from discovery research, to technology and product development, to late stage process development, and to commercial opera ons.Dr. Luo graduated from Virginia Tech with his Ph.D. in Microbiology and Immunology. He was trained as a postdoc at the Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Ins tute, Harvard Medical School.In 2010, Dr. Luo was awarded Science and Technology Innova on award at Amgen (for his work on Mab produc vity of 11g/L at 2000 L scale). He also led a team at Jianshun Biosciences achieved an ATF-based perfusion process at 1.5 g/L/day produc vity recently.

Line-up

本 社

関 西 支 所

ホームページ

〒104-8402　東京都中央区築地6 - 1 9 - 2 0TEL.03（3248）2207　FAX.03（3248）2243〒530-0043　大 阪 市 北 区 天 満 1 - 3 - 2 1TEL.06（6357）2128　FAX.06（6357）2330https://www.nichirei.co.jp/bio/

2020.10

Product List

CD Media for CHO cells (Celkey™)

CD Media, LSM, SFM for Vet Vaccine

* CD: Chemical Defined LSM: Low-Serum Media, SFM: Serum-Free Media

CELL LINE

EB66

Fed-batchCHO-S,CHO-K1,DG44, DXB11…

CD CHO 011, CD CHO 014, CD CHO 017,CD CHO 022, CD CHO 050, CD CHO 051

CD Feed 002, CD Feed 008,CD Feed 009, CD Feed 011

CD EB66PoultryVaccine-

BHK21 BHK21 LSMBHK21 SFMFMDBEFATCC CCL-10

CD CHO 014, CD CHO 051Perfusion

CD Transfection MediumTransfection

VEROPPRVPEDVATCC-CCL81

ST CD STPRV, CSFVTGEV, PEDVATCC CRL-1746

MDBK CD MDBKIBRVBVDV-

MDCK

CD MDCKCD MDCK Production Media

Adenoviruses Expression of recombinant proteins

AIVATCC CCL-34

ISOLATE PRODUCTSAPPLICATION

CELL LINE PRODUCTSAPPLICATION

CELL LINE

PK15 CD PK15

CD VERO

HEK293Adeno-virusesATCC CRL-1573 CD HEK293

Sf9/sf21 - Insect SFM

HS - HS SFM

PCV, TEGVPPVATCC CCL-33

ISOLATE PRODUCTSAPPLICATION

Base Media Feed Media

株式会社ニチレイバイオサイエンスでは、長年にわたり細胞培養関連製品を取り扱ってまいりました経験がございます。J ian shun B i o s c i ence s の輸入販売元として高品質な培地製品をお届けいたします。